L. Civitano

A Multiphase Model of the Dynamics of HBV Infection in Hbeag-Negative Patients during Pegylated Interferon-α2A, Lamivudine and Combination Therapy

P. Colombatto, L. Civitano, Ranieri Bizzarri et al. · Antiviral Therapy · 2006 · 57 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Sustained Response to Interferon–Ribavirin Combination Therapy Predicted by a Model of Hepatitis C Virus Dynamics Using Both Hcv Rna and Alanine Aminotransferase

P. Colombatto, L. Civitano, Filippo Oliveri et al. · Antiviral Therapy · 2003 · 34 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Early and Accurate Prediction of Peg-IFNs/Ribavirin Therapy Outcome in the Individual Patient With Chronic Hepatitis C by Modeling the Dynamics of the Infected Cells

P. Colombatto, P. Ciccorossi, A.M. Maina et al. · Clinical Pharmacology & Therapeutics · 2008 · 13 citations

Medicine, Infectious Diseases, Pharmacology +17